Company Filing History:
Years Active: 1989
Title: Keiko Hasegawa: Innovator in Pharmaceutical Chemistry
Introduction
Keiko Hasegawa is a prominent inventor based in Inazawa, Japan. She has made significant contributions to the field of pharmaceutical chemistry, particularly through her innovative work on glycyrrhetic acid derivatives. Her research has the potential to impact various therapeutic applications.
Latest Patents
Hasegawa holds a patent for glycyrrhetic acid derivatives and their use as pharmaceutical agents. The patent describes a glycyrrhetic acid derivative characterized by specific chemical formulas and functional groups. This innovation highlights her expertise in developing compounds that may serve important roles in medicine.
Career Highlights
Throughout her career, Hasegawa has demonstrated a commitment to advancing pharmaceutical research. Her work at Sanwa Kagaku Kenkyusho Co., Ltd. has positioned her as a key figure in the development of new therapeutic agents. She has successfully navigated the complexities of patent applications, ensuring her inventions are protected and recognized.
Collaborations
Hasegawa has collaborated with notable colleagues, including Masayasu Kurono and Ryoichi Unno. These partnerships have fostered a collaborative environment that enhances the innovation process and contributes to the advancement of their shared research goals.
Conclusion
Keiko Hasegawa's contributions to pharmaceutical chemistry through her patented innovations exemplify her dedication to improving healthcare solutions. Her work continues to inspire future advancements in the field.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.